Swiss-based DSM Nutritional Products (DNP) has entered the olive-sourced hydroxytyrosol market that has been hot since the European Food Safety Authority (EFSA) issued a rare plant polyphenol health claim approval in 2011.
Mid-last year the chief of Norwegian omega-3 player EPAX told us, “We are the last of the big omega-3 independents.” Soon after US agri-food company FMC had snapped it up for $350m. Here FMC Nutraceuticals general manager Daniel H. Rosenbaum talks through...
Non-members of the International Fishmeal and Fish Oil Organization (IFFO) are able to apply for ‘responsible supply’ (RS) certification, after the body altered its criteria recently.
DSM has delivered a Q3 increase in EBITDA earnings of 27% across all its divisions despite “headwinds” like the ongoing economic flatline in Europe and elsewhere, challenging currency movements and rising ingredient costs.
DSM Nutritional Products has applied for an EU novel foods extension for a micro-algae-derived DHA (docosahexaenoic acid) omega-3 form to be used in infant formula products.
Blood levels of DHA and other omega-3s are directly related to measures of cognition and behavior in schoolchildren with below average reading ability, says a new study from the UK.
Epax CEO Ola Snove thinks the €2bn BASF and DSM buying frenzy that saw many major suppliers consolidated in their hands is ultimately a good thing for the €20bn+ sector – but its independence remains valued at Epax.
A Norwegian start-up says its patent pending compression technology has allowed it to commercialise omega-3 powder that can be formulated in hard tablets rather than capsules.
DSM says the supply bottleneck in fish-sourced omega-3 that recently forced its own prices up 15%, is not confined to the dominant source – Peruvian anchovies.
DSM’s bulging lipid business has bumped fish-sourced omega-3 oil prices 15% as crude fish oil stock prices skyrocket in the face of increasing demands on global fisheries.
Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.
BASF’s ever-expanding nutrition unit says its €644m bid last week bid for Norwegian omega-3 firm, Pronova Biopharma, is as important for its food supplements business as its pharmaceutical operations.
Norwegian omega-3 specialist Smartfish has added a third component to its Smartfish Medical range – this time upping the ante from 1100mg to 2000mg of EPA and DHA omega-3s.
Royal DSM has emphasised “business continuity” and “smooth integration” following the completion of its $CAD540m (€436m) buy-out of the world’s largest omega-3 fish oil supplier, Ocean Nutrition Canada (ONC), today.
Increased levels of the omega-3 DHA may be associated with improved literacy in children with learning difficulties, according to a new study from Australia.
DSM will use its global reach to drive its latest acquisition - fish-sourced omega-3 leader, Ocean Nutrition Canada, beyond its core North American market – but sees opportunities in generic drugs that may prove more lucrative.
Lonza has reformulated its omega-3 range using its proprietary algal strain and sunflower oil – developments it says offer cost and matrix flexibility.
High intake of the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) could help protect the aging brain, according to research.
A fish oil supplement enriched with DHA may benefit early communicative development in infants, says the first randomized controlled trial testing high dose omega-3 on brain development in non-premature infants
Ocean Nutrition Canada has applied to have an omega-3 algal oil approved under European Union novel foods regulations – stating it is ‘substantially equivalent’ to an existing approved oil manufactured by Martek-DSM.
Cargill is celebrating the European Union approval of a Mortierella alpine, algae fermented arachidonic acid (ARA)-rich oil, to be used in infant formula and formula for older children.
With the volume of omega-3 science tripling in 10 years, the world’s leading omega-3 trade group is working with international regulators to have that research reflected in authorised claims – especially in the EU and the US.
US troops and service personnel with low levels of omega-3 are at increased risk of suicide, says a new study that potential opens the door to widespread omega-3 supplementation.
The dynamics of the algal omega-3 market are set to change over the next 18 months with the entrance of two new players both promising to trump the competition in the efficiency and sustainability stakes.
DHA (docosahexaenoic acid) is the critical omega-3 fatty acid in the brain and research backs its ability to boost brain function. But can it slow the onset of Alzheimer’s Disease and help protect sportspeople against concussion?
Controversial DHA omega-3 infant eye claims have entered European Union law after narrowly averting a last-minute challenge in the European Parliament that would have sent the claims back to the drawing board.
High doses of the omega-3 fatty acid DHA in baby formula or breast milk may have ‘modest, positive effects’ on the growth of the pre-term infants, including increased length, says a new study from Australia.
Members of the European Parliament (MEPs) have today narrowly rejected a motion to prohibit a European Food Safety Authority (EFSA) and European Commission (EC)-approved DHA omega-3 eye health claim on breast milk substitute products.
Royal DSM has kicked the integration of its new €800m wholly-owned subsidiary, Martek Biosciences Corporation, into life by establishing a special integration unit to manage the US-Dutch-Swiss deal.
Stakeholder input can alter European Food Safety Authority health claim opinions, says German consultancy and contract research organization, Analyze&Realize, even if the examples are few.
Greenback Acquisition Corporation, a wholly-owned Royal DSM subsidiary, has begun the formal tender for Martek Biosciences, which DSM announced it was buying for €829m ($1.087bn) last month.
Supplements of the omega-3 fatty acid DHA (docosahexanoic acid) may prevent traumatic brain injury, according to a new study with rats with potential implications for sportsmen and soldiers.
An article 14 children’s development health claim submitted to the European Union by drug giant Merck linking omega-3 form DHA with infant visual development has been approved at committee level by the European Commission.
The Global Organization for EPA and DHA Omega-3 (GOED) sent a last-minute letter to member states ahead of yesterday’s European Commission meeting for brain health claims for omega-3 forms, ALA and DHA.
Martek Bioscience has said it is expanding its omega-3 range by commercializing two new products – a new emulsion version of its vegetarian life’s DHA and a DHA/EPA blend from algal sources.
Crucial. Claims. Knowledge. With industry still reeling from the latest batch of article 13.1 opinions, NutraIngredients has been busy putting the final touches on its second health claims conference in Brussels – now less than a month away.
Daily supplements of docosahexaenoic acid (DHA) were ‘not useful’ in reducing cognitive decline associated with mild-to-moderate Alzheimer’s disease, says a new study.
